19 April 2010 – Study results discussed at the European Association of Urology (EAU) Congress in Barcelona, have reinforced the association between nocturia and a greater risk of falls and mortality.
In a population-representative study in Japan by Nakagawa et al, it was concluded that adults who suffered from nocturia (defined as two or more episodes of voids/urination per night) had a significantly increased risk of mortality when compared to adults without nocturia, even once adjustments had been made for other contributing factors (e.g. age, gender, physiological conditions)... Ferring Pharmaceuticals' Press Release -
Blog Archive
-
▼
2010
(38)
-
▼
April
(11)
- MicroLight : laser treats fibromyalgia
- Ferring Pharmaceuticals : Wake Up to Nocturia - St...
- Cephalon : Complete Response Letter for NUVIGIL fo...
- Arena Pharmaceuticals : Initiation of Phase 1 Clin...
- SOMAXON : FDA APPROVAL OF SILENOR® (DOXEPIN) FOR ...
- GE’s Virtual Sleep Lab Enables Sleep Apnea Testing...
- ImThera Medical Successfully Implants First Patien...
- Lupin : FDA tentative approval for Eszopiclone tab...
- Vantia Therapeutics' lead candidate VA106483 enter...
- ResMed : Next-Generation CPAP Series in Europe
- Apnex Medical : Additional $14 Million
-
▼
April
(11)